Global CAR-T Therapy Overview 2017 – Research and Markets – Business Wire (press release)
|
Global CAR–T Therapy Overview 2017 – Research and Markets
Business Wire (press release) CAR-T or Chimeric Antigen Receptor T cells are a sub component of Adoptive T Cell therapy (ACT), a promising new treatment intervention for cancer. In ACT, a patient's individual T cells are removed and manipulated so they have an increased capacity to … |
